Glicazide 60mg Metformin 500mg | Brand – Glimek-M | Manufacturer – Nest Healthcare | Pack of 1X10Tab

Glimek-M Tablets are a combination of Gliclazide (60mg) and Metformin Hydrochloride (500mg), used in the management of Type 2 Diabetes Mellitus. This dual-action oral anti-diabetic therapy helps control blood sugar levels effectively by enhancing insulin secretion and improving insulin sensitivity.

Key Benefits:

• Combination therapy provides superior glycemic control

• Gliclazide stimulates pancreatic insulin secretion

• Metformin reduces hepatic glucose production and increases peripheral insulin sensitivity

• May help delay diabetes-related complications

• Suitable as second-line treatment in Type 2 Diabetes

Composition:
Each uncoated tablet contains:

• Gliclazide IP – 60mg (Modified Release)

• Metformin Hydrochloride IP – 500mg (Immediate Release)

• Excipients q.s.

Recommended Usage:

• To be used under medical supervision only

• Usually taken once or twice daily with meals to reduce gastrointestinal side effects

• Dosage should be individualized based on patient’s blood sugar levels and physician’s advice

Storage Instructions:
Store below 25°C in a dry place. Protect from moisture and light. Keep out of reach of children.

Regulatory Information:

• Schedule H Prescription Drug – Not to be sold without a valid prescription from a Registered Medical Practitioner.

• This product is intended for retail sale only, not for wholesale distribution.

Caution:

• Regular monitoring of blood glucose levels is advised

• Use with caution in patients with kidney or liver impairment

• Not recommended in pregnancy or lactation unless advised by a physician